Discovery of dual GPBAR1 agonist and cysteinyl leukotriene receptor (CysLTR)1 antagonist for treating drug induced liver injury

Published: 5 January 2022| Version 1 | DOI: 10.17632/3xvs65zmhm.1
Contributors:
,
silvia marchianò,
Stefano Fiorucci

Description

In this research we have investigated the potential protective action of a dual GPBAR1 and CYSTLTR1 modulator in the development of hepatic inflammation and fibrosis in mice models of liver injury caused by acethaminophen (APAP) or CCL4

Files

Institutions

Universita degli Studi di Perugia

Categories

Transcriptomics

License